Senior Director Product Management

Danaher Corporation

24d•Onsite

About The Position

The Senior Director, Product Management is a senior strategic leader responsible for shaping, expanding, and delivering Cytiva’s viral vector product portfolio—extending well beyond AAV. This role defines long‑range product vision, guides innovation investments, and enables deep commercial alignment to support customers developing and manufacturing viral‑vector–based therapeutics. This leader will oversee a high‑performing team of 5–6 product managers and partner closely across R&D, Commercial, Operations, Regulatory, and Executive Leadership to strengthen Cytiva’s position as a trusted partner across AAV, LV, and emerging vector‑based bioproduction workflows. This position reports to the Vice President & General Manager – Viral Vector, Genomic Medicine and is part of the Viral Vector business unit with Genomic Medicine located in Marlborough, MA; Uppsala, Sweden; Cologne, Germany; Amersham, UK; or Portsmouth, UK, and will be an on-site role.

Requirements

10+ years of relevant experience in the (bio‑)pharmaceutical industry or academic research, with a proven track record of advancing complex programs.
Demonstrated ability to thrive and lead within a highly matrixed, global organization—building alignment, influencing diverse stakeholders, and driving cross‑functional execution.
Deep expertise in product and biopharmaceutical development, including end‑to‑end understanding from early research to commercialization; experience in viral vector drug development strongly preferred.
Strategic leader with the ability to craft and articulate bold, forward‑looking strategies and translate them into actionable, high‑impact plans.
Strategic thinker who connects science, market dynamics, and business value.
Exceptional communication, storytelling, and executive‑level presentation skills, capable of inspiring teams and influencing decision‑making at all levels.
Entrepreneurial, results‑driven mindset, with a strong sense of ownership and a passion for delivering on commitments in a dynamic, fast‑paced environment.
Enterprise‑minded collaborator who influences across functions and geographies.
Demonstrated ability to translate complex scientific concepts (e.g., AAV/LV vectors, upstream/downstream workflows, analytical methods, regulatory trends) into compelling strategic recommendations for senior executives, commercial partners, and customers across biotech, CDMOs, and therapeutic developers.

Nice To Haves

Proven leadership in fast‑growing or transformational environments, ideally within organizations driving innovation in genomic medicine.
Strong business acumen, including experience shaping portfolio decisions, managing budgets, and assessing program or market risk.
Comfortable operating in ambiguity and bringing structure to evolving spaces.
Strong capability in bringing structure—through frameworks, governance mechanisms, and customer‑backed insights—to accelerate innovation and drive organizational alignment.

Responsibilities

Develop and drive a clear product vision and multi-year roadmap, grounded in market intelligence, customer needs, and competitive insights to inform critical portfolio decisions.
Translate complex scientific and technical requirements into actionable product strategies, engaging directly with KOLs, clinicians, and biotech innovators to define high value features and solutions.
Deliver innovation on time and on budget—across internal development and external collaborations—while ensuring strong product revenue and margin performance.
Serve as the strategic bridge between technical and business stakeholders, partnering closely with R&D, Manufacturing, Regulatory, and Commercial teams to enable timely, high quality product development and launches.
Own the full product lifecycle, from concept through commercialization, including post launch monitoring, performance optimization, and continuous improvement driven by customer feedback and emerging technologies.
Shape the viral vector business unit strategy, balancing near, mid, and long term innovation and execution priorities in alignment with GenMed and Cytiva’s enterprise strategy.